PD Dr. Carolin Hack

Medizinische Fakultät

Integration von Komplementärmedizin in die Uroonkologie (2025) Hack C, Seitz K, Thederan I, Wüfling P, Wullich B, Bellut L, Herrmann HJ, Zopf Y Journal article Validation of the Questionnaire for the Structured Assessment of the Use of Complementary Medicine Methods and Procedures in Patients from the S3 Guideline Complementary Medicine in Oncology and Practical Use of it in Patients with Gynecological Cancer Validierung des Fragebogens f r die strukturierte Bewertung der Nutzung komplement rmedizinischer Methoden und Verfahren aus der S3-Leitlinie zur Komplement rmedizin in der Onkologie und praktischer Einsatz bei Patientinnen mit gyn kologischem Krebs (2025) Seitz K, Theuser AK, Hack C, Fasching P, Emons J, Brückner L, Au K, et al. Journal article Evaluating the potential of ChatGPT for patient identification in clinical breast cancer trials (2025) Krückel A, Fasching P, Schleicher O, Gocke J, Brückner L, Seitz K, Häberle L, et al. Journal article The impact of physical activity on progression-free and overall survival in metastatic breast cancer based on molecular subtype (2024) Ziegler P, Hartkopf AD, Wallwiener M, Häberle L, Kolberg HC, Hadji P, Tesch H, et al. Journal article The Influence of Physical Training on Breast Cancer: The Role of Exercise-Induced Myokines in Regulating Breast Cancer Cell Growth and Survival (2024) Natarajan A, Pradhan R, Dieterich W, Schwappacher R, Reljic D, Herrmann HJ, Neurath M, et al. Journal article Prognosis prediction with the IHC3 score in patients with node-negative, hormone receptor-positive, HER2-negative early breast cancer (2024) Seitz K, Goossens C, Hübner H, Gaß P, Uhrig S, Heindl F, Emons J, et al. Journal article Tumor-Associated Neutrophils Are a Negative Prognostic Factor in Early Luminal Breast Cancers Lacking Immunosuppressive Macrophage Recruitment (2024) Schmidt E, Distel L, Erber R, Büttner-Herold M, Rosahl MC, Ott O, Strnad V, et al. Journal article Prognostic impact of selection criteria of current adjuvant endocrine therapy trials NATALEE and monarchE in postmenopausal HRpos/HER2neg breast cancer patients treated with upfront letrozole (2024) Fasching P, Hack C, Nabieva N, Maass N, Aktas B, Kümmel S, Thomssen C, et al. Journal article CDK4/6 Inhibition – Therapy Sequences and the Quest to Find the Best Biomarkers – an Overview of Current Programs (2024) Schneeweiss A, Brucker SY, Hübner H, Volmer LL, Hack C, Seitz K, Rübner M, et al. Journal article, Review article Initial experience with a next-generation low-field MRI scanner: Potential for breast imaging? (2024) Dietzel M, Laun FB, Heiß R, Wenkel E, Bickelhaupt S, Hack C, Uder M, Ohlmeyer S Journal article